Michael E. Feigin
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Wnt/β-catenin signaling in development and cancer 7
- Receptor Mechanisms and Signaling 5
- Cancer-related gene regulation 4
- Oncology 8
- Pancreatic and Hepatic Oncology Research 5
- Cancer Cells and Metastasis 3
- Co-authors
- Craig C. Malbon (4 shared papers)Senthil K. Muthuswamy (7 shared papers)Rama Kamesh Bikkavilli (2 shared papers)Molly Gale Hammell (1 shared paper)Bin Xue (1 shared paper)Avi Z. Rosenberg (3 shared papers)Hal K. Berman (1 shared paper)Lakshmi B. Muthuswamy (1 shared paper)
- Journals
- Journal of Cell Science (4 papers)Nature Genetics (1 paper)Science Advances (1 paper)Cancer Research (1 paper)Molecular Cancer Research (1 paper)
- Partner nations
- United StatesCanadaSaudi Arabia
In The Last Decade
Michael E. Feigin
23 papers receiving 2.6k citations
Michael E. Feigin's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 1.3k
- Cancer Research 515
- Molecular Biology 1.2k
- Cell Biology 271
- Biotechnology 114
Countries citing papers authored by Michael E. Feigin
This map shows the geographic impact of Michael E. Feigin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Feigin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Feigin more than expected).
Fields of papers citing papers by Michael E. Feigin
This network shows the impact of papers produced by Michael E. Feigin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Feigin. The network helps show where Michael E. Feigin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Feigin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Organoid Models of Human and Mouse Ductal Pancreatic Cancer Hit paper breakdown → | 2014 | 1753 |
| 2 | 2008 | 166 | |
| 3 | 2018 | 102 | |
| 4 | 2014 | 97 | |
| 5 | 2009 | 77 | |
| 6 | 2008 | 71 | |
| 7 | 2014 | 70 | |
| 8 | 2017 | 47 | |
| 9 | 2008 | 39 | |
| 10 | 2007 | 33 | |
| 11 | 2012 | 32 | |
| 12 | 2013 | 28 | |
| 13 | 2008 | 26 | |
| 14 | 2023 | 26 | |
| 15 | 2020 | 19 | |
| 16 | 2022 | 19 | |
| 17 | 2022 | 18 | |
| 18 | 2021 | 16 | |
| 19 | 2016 | 9 | |
| 20 | 2024 | 7 |
About Michael E. Feigin
Michael E. Feigin is a scholar working on Molecular Biology, Oncology, Cell Biology, Cellular and Molecular Neuroscience and Cancer Research, having authored 24 papers that have together received 2.7k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (7 papers), Receptor Mechanisms and Signaling (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer-related gene regulation (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Cancer Cells and Metastasis (3 papers), Neuropeptides and Animal Physiology (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (515 citations), Molecular Biology (1.2k citations), Cell Biology (271 citations) and Biotechnology (114 citations). Michael E. Feigin has collaborated with scholars based in United States, Canada and Saudi Arabia. Frequent co-authors include Craig C. Malbon, Senthil K. Muthuswamy, Rama Kamesh Bikkavilli, Molly Gale Hammell, Bin Xue, Avi Z. Rosenberg, Hal K. Berman, Lakshmi B. Muthuswamy, S. Dipikaa Akshinthala and Kiyomi Y. Araki. Their work appears in journals such as Journal of Cell Science, Nature Genetics, Science Advances, Cancer Research and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.